Reshape Biotech

Reshape Biotech builds robotic imaging and AI-analysis infrastructure for microbiology laboratories. Its platform automates incubation, image capture, result classification and digital traceability across research and quality-control workflows. Founded in Copenhagen in 2018, Reshape says its systems support institutions including Syngenta and the University of Oxford and are expanding into regulated laboratory operations.

Facts

Segment: Lab Automation
Country: Denmark
Founded: 2018
Website: https://www.reshapebiotech.com/

Funding

2025-02-17 - Series A - $20M - Reshape Biotech raises $20 million Series A - Reshape Biotech raised a $20 million Series A led by Astanor Ventures to expand its laboratory-automation platform and U.S. operations. - source: reshapebiotech.com

View funding

Investors

ACME - Participant - Unknown - 1 funding event - first seen 2025-02-17
Astanor Ventures - Lead - VC - 1 funding event - first seen 2025-02-17
Nicholas Francis - Participant - Angel / Individual - 1 funding event - first seen 2025-02-17

View investors

Market context

Comparable profiles and adjacent companies connected by shared workflow, capability, or stack position.

Automata - comparable profile - peer: Lab Automation Platform Builder
Biosero - comparable profile - peer: Lab Automation Platform Builder
Medra - comparable profile - peer: Lab Automation Platform Builder

View market context

Timeline

2026-05-06 - Capability - Reshape upgrades high-throughput microbiology imaging system - The upgrade adds a universal in-feed for standard 90-millimetre Petri dishes used in ISO-compliant laboratories and portable magazines holding up to 24 plates. A compressed-air lid-separation mechanism addresses stuck plates, while an on-device screen shows… - source: reshapebiotech.com

View timeline

Team

Carl-Emil Grøn - Co-founder and Chief Executive Officer
Magnus Madsen - Co-founder and Chief Commercial Officer

View team